Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Shares Issued (2016 - 2024)

CNBX Pharmaceuticals (CNBX) has disclosed Shares Issued for 10 consecutive years, with $30000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Shares Issued rose 20.03% year-over-year to $30000.0, compared with a TTM value of $54993.0 through Nov 2024, up 120.03%, and an annual FY2019 reading of $7.3 million, up 370.6% over the prior year.
  • Shares Issued was $30000.0 for Q4 2024 at CNBX Pharmaceuticals, up from $24993.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $30000.0 in Q4 2024 and bottomed at $24993.0 in Q4 2023.